Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study

被引：0

作者：

Vieito Villar, M. ^{[1
]}

Sepulveda Sanchez, J. M. ^{[2
]}

Moreno Garcia, V. ^{[3
]}

Lombardi, G. ^{[4
]}

Stradella, A. ^{[5
]}

Dahlrot, R. H. ^{[6
]}

Haslund, C. A. ^{[7
,8
]}

Geurts, M. ^{[9
]}

Pineda, E. ^{[10
]}

Brandal, P. ^{[11
]}

De Vos, F. Y. F. L. ^{[12
]}

Vaz Salgado, M. A. ^{[13
]}

Martinez Garcia, M. ^{[14
]}

Macchini, M. ^{[15
]}

Amoroso, B. ^{[16
]}

Sanchez, T. ^{[16
]}

Hanna, B. ^{[17
]}

Li, X. ^{[17
]}

Nikolova, Z. ^{[16
]}

Simonelli, M. ^{[18
,19
]}

机构：

[1] Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain

[2] Hosp Univ 12 Octubre, Med Oncol, Madrid, Spain

[3] Hosp Univ Fdn Jimenez Diaz, START Madrid FJD, Madrid, Spain

[4] IOV IRCCS, Ist Oncol Veneto, Dept Oncol, Oncol 1, Padua, Italy

[5] Inst Catala Oncol, Dept Med Oncol, Barcelona, Spain

[6] Odense Univ Hosp, Dept Oncol, Odense, Denmark

[7] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark

[8] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark

[9] Erasmus MC Canc Inst, Dept Neurol, Rotterdam, Netherlands

[10] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[11] Oslo Univ Hosp, Dept Oncol, Oslo, Norway

[12] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands

[13] Hosp Univ Ramon y Cajal, Dept Med Oncol, Madrid, Spain

[14] Hosp del Mar, Dept Med Oncol, Barcelona, Spain

[15] IRCCS San Raffaele Sci Inst, Med Oncol, Milan, Italy

[16] Ctr Innovat & Translat Res Europe, Early Clin Dev, Seville, Spain

[17] Bristol Myers Squibb, Clin Pharmacol, Princeton, NJ USA

[18] Humanitas Univ, IRCCS Humanitas Res Hosp, Dept Hematol & Oncol, Milan, Italy

[19] Humanitas Univ, Dept Biomed Sci, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1694

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

500O

引用

页码：S392 / S392

页数：1

共 50 条

[21] RADIOTHERAPY (RT) WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE (TMZ) IN GLIOBLASTOMA MULTIFORME (GBM) - LONG TERM RESULTS FROM A SINGLE UNITED KINGDOM CENTRE
Haylock, B.
Husband, D.
Shenoy, A.
Wong, H.
Brodbelt, A.
Walker, C.
RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S34 - S35
[22] A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS
Bota, Daniela A.
Kesari, Santosh
Piccioni, David
Aregawi, Dawit
Roth, Patrick
Stupp, Roger
Desjardins, Annick
Reich, Steven D.
Elias, Ileana
Li, Mingyu
Levin, Nancy
Winograd, Benjamin
Mason, Warren
NEURO-ONCOLOGY, 2018, 20 : 20 - 20
[23] EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma
Brandes, Alba A.
Stupp, Roger
Hau, Peter
Lacombe, Denis
Gorlia, Thierry
Tosoni, Alicia
Mirimanoff, Rene O.
Kros, Johan M.
van den Bent, Martin J.
EUROPEAN JOURNAL OF CANCER, 2010, 46 (02) : 348 - 354
[24] Is long-term survival in Glioblastoma possible? Updated results of the EORTC/NCIC phase III randomized trial on radiotherapy (RT) and concomitant and adjuvant Temozolomide (TMZ) versus RT alone
Mirimanoffr, R.
Mason, W.
Van den Bent, M.
Kortmann, R.
Taphoorn, M.
Brandes, A.
Villa, S.
Cairncrosss, G.
Gorlia, T.
Stupp, R.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S2 - S2
[25] Mature results of a phase I/IIA trial of the integrin inhibitor cilengitide (EMD121974) added to standard concomitant and adjuvant temozolomide and radiotherapy (TMZ/RT) for newly diagnosed glioblastoma (GBM)
Stupp, Roger
Goldbrunner, Roland
Neyns, Bart
Schlegel, Uwe
Clement, Paul
Grabenbauer, Gerhard
Hegi, Monika
Nippgen, Johannes
Picard, Martin
Weller, Michael
NEURO-ONCOLOGY, 2007, 9 (04) : 517 - 517
[26] NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS
Khasraw, Mustafa
McDonald, Kerrie
Yip, Sonia
Verhaak, Roel
Heimberger, Amy
Hall, Merryn
Fisher, Lauren
Barnes, Elizabeth
Rosenthal, Mark
Gedye, Craig
Hovey, Elizabeth
Ellingson, Benjamin
Simes, John
Tognela, Annette
Koh, Eng-Siew
Gan, Hui
Back, Michael
Lwin, Zarnie
NEURO-ONCOLOGY, 2018, 20 : 235 - 235
[27] NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress
Khasraw, Mustafa
McDonald, Kerrie L.
Yip, Sonia
Verhaak, Roel
Heimberger, Amy
Hall, Merryn
Fisher, Lauren
Barnes, Elizabeth
Rosenthal, Mark
Gedye, Craig
Hovey, Elizabeth
Ellingson, Benjamin M.
Simes, John
Tongela, Annette
Wheeler, Helen
Koh, Eng-Siew
Gan, Hui
Back, Michael
Lwin, Zarnie
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 196 - 197
[28] Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy
Jennifer A. Quinn
Sara Xiaoyin Jiang
David A. Reardon
Annick Desjardins
James J. Vredenburgh
Allan H. Friedman
John H. Sampson
Roger E. McLendon
James E. Herndon
Henry S. Friedman
Journal of Neuro-Oncology, 2009, 95 : 393 - 400
[29] Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy
Quinn, Jennifer A.
Jiang, Sara Xiaoyin
Reardon, David A.
Desjardins, Annick
Vredenburgh, James J.
Friedman, Allan H.
Sampson, John H.
McLendon, Roger E.
Herndon, James E., II
Friedman, Henry S.
JOURNAL OF NEURO-ONCOLOGY, 2009, 95 (03) : 393 - 400
[30] TUMOR TREATING FIELDS (TTFIELDS) THERAPY WITH CHEMORADIATION, FOLLOWED BY MAINTENANCE TTFIELDS THERAPY/TEMOZOLOMIDE (TMZ), IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM). RESULTS OF PHASE II CLINICAL STUDY
Grossman, Rachel
NEURO-ONCOLOGY, 2024, 26

← 1 2 3 4 5 →